RBR-8w9rzy招募中未知
Comparison between Radioembolization with 131I-Lipiodol and Transarterial chemoembolization in Hepatocellular carcinoma treatment
Faculdade de Medicina de Botucatu/ Universidade Estadual Paulista0 个研究点开始时间: 2020年1月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 130Y（—）
入选标准
- •Age of 18 years-old or older; hepatocellular carcinoma graded as intermediate or advanced; liver cirrhosis; performance status of 0 or 1 at the time of the treatment; with contrast-administrated imaging exams before the treatment to assess the treatment response.
排除标准
- •Another neoplastic disease; incomplete study procedures; lack of imaging exams during the follow-up; other severe ilnesses in advanced stage that could be more harmful to the patient survival than the hepatocellular carcinoma and the liver cirrhosis, such as chronic obstructive pulmonar disease, cardiac insuficiency, immunosupression (caused by HIV infection or drug-induced) or dialytic kidney insuficiency; pregnant or lactating women.
研究者
相似试验
进行中（未招募）
4 期
Safety and Efficacy of Ho-166-Radioembolisation by SPECT- and MR-Image guidance optimized substrate application - a comparative Study to Y-90-RadioembolisatioC18C50Malignant neoplasm of colonMalignant neoplasm of breastDRKS00014139niversitätsklinikum Magdeburg11
已完成
2 期
Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular CarcinomaHepatoCellular CarcinomaNCT03033446National Cancer Centre, Singapore40
进行中（未招募）
不适用
Study of Radioembolization (RE) with SIR-Spheres® versus Transarterial Chemoembolisation (TACE) in patients with unresectable primary Hepatocellular Carcinoma. A comparative, prospective, randomised, open, pilot trial to evaluate health-related quality of life, pharmaco-economic parameters, and efficacy. - SIRTACE-HCC pilot studynresectable primary hepatocellular carcinoma (pHCC)MedDRA version: 9.1Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableEUCTR2006-006478-79-DESIRTEX Medical Europe28
招募中
2 期
Radiotherapy of soft tissue sarcomaIRCT20180919041070N3Iran University of Medical Sciences80
已完成
2 期
Holmium-166-radioembolization in patients with unresectable hepatocellular carcinoma; a multi-center, interventional, non-randomized, non-comparative, open label, early phase II study: HEPAR Primaryliver cancerNL-OMON44682niversitair Medisch Centrum Utrecht30